Letter to the editor

Recent studies on resveratrol and its biological and pharmacological activity

Yong Joo Kim1, Sun Ok Chung1, Jae Kwang Kim2[*], Sang Un Park3

1Department of Biosystems Machinery Engineering, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Korea

2Department of Crop Science, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Korea

3Division of Life Sciences and Convergence Research Center for Insect Vectors, Incheon National University, Incheon 22012, Korea

EXCLI J 2017;16:Doc602

 

Dear Editor,

Resveratrol (3,5,4′-trihydroxy-trans-stilbene) is a stilbenoid and polyphenolic compound. It is found naturally, especially in plants sources such as peanuts, grapes, and some berries (Diaz-Gerevini et al., 2016[9]). In plants, resveratrol is produced via the phenylpropanoid pathway. It is derived from p-coumaric acid, which is an intermediate formed during lignin production. The 4-coumarate:coenzyme A (CoA) ligase converts p-coumaric acid to coumaroyl-CoA, along with three units of malonyl-CoA, which are then condensed to form resveratrol by resveratrol synthase or stilbene synthase (Deng et al., 2016[8]; Zhang et al., 2015[55]; Zheng et al., 2015[57]; Kim et al., 2013[21]).

Resveratrol is the most widely studied plant-derived polyphenol. Several studies have been reported on its numerous biological and pharmacological effects. These include neuroprotective (Su et al., 2016[45]), antiobesity (Chang et al., 2016[5]), antiviral (Abba et al., 2015[1]), hepatoprotective (Faghihzadeh et al., 2015[11]), anti-inflammatory (Liu et al., 2015[27]), cardioprotective (Raj et al., 2015[40]), anticancer (Kumar et al., 2015[22]), anti-atherogenic (Riccioni et al., 2015[41]), antidiabetic (Szkudelski and Szkudelska, 2015[46]), and antioxidant (Yun et al., 2014[53]) activities. Resveratrol shows a wide range of biological activities and health benefits in humans, which makes it a beneficial substance for use in the pharmaceutical, food, and cosmetic industries. We present a review of the most recent studies on the benefits of resveratrol, especially its biological and pharmacological activities (Table 1(Tab. 1)). (References in Table 1: Zhai et al., 2016[54]; Hyatt et al., 2016[14]; Tsang et al., 2016[49]; Rai et al., 2016[39]; Li et al., 2016[25]; Jin et al., 2016[18]; Abdel-Wahab et al., 2016[2]; Kim et al., 2016[20]; Su et al., 2016[45]; Lai et al., 2016[23]; Hu et al., 2016[13]; Monserrat Hernández-Hernández et al., 2016[32]; Natalin et al., 2016[33]; Chang et al., 2016[5]; Polley et al., 2016[37]; Bedada et al., 2016[4]; Shah et al., 2016[43]; Khazaei et al., 2016[19]; Li et al., 2016[26]; Das et al., 2015[7]; Wang et al., 2015[50]; Meng et al., 2015[31]; Tan et al., 2016[47]; Sin et al., 2015[44]; Ishikawa et al., 2015[15]; Lu and Wang, 2015[28]; Ji et al., 2015[17]; Rabassa et al., 2015[38]; Pektaş et al., 2015[35]; Jang et al., 2015[16]; Meftahi et al., 2015[30]; Dong et al., 2015[10]; Pereira et al., 2015[36]; Schroeter et al., 2015[42]; Lee et al., 2015[24]; Yaylali et al., 2015[52]; Arslan et al., 2015[3]; Trung et al., 2015[48]; Ortega and Duleba, 2015[34]; Riccioni et al., 2015[41]; Mastromarino et al., 2015[29]; Yao et al., 2015[51]; Cigremis et al., 2015[6]; Zhao et al., 2015[56]; Ge et al., 2015[12].)

Notes

Jae Kwang Kim and Sang Un Park (Division of Life Sciences and Convergence Research Center for Insect Vectors, Incheon National University, Incheon 22012, Korea; Phone: +82-42-821-5730, E-mail: supark@cnu.ac.kr) contributed equally as corresponding authors.

Acknowledgements

This research was supported by Agriculture, Food and Rural Affairs Research Center Support Program, Ministry of Agriculture, Food and Rural Affairs.

Conflict of interest

The authors declare no conflict of interest.

 

References

1. Abba Y, Hassim H, Hamzah H, Noordin MM. Antiviral activity of resveratrol against human and animal viruses. Adv Virol. 2015;2015:184241.
2. Abdel-Wahab BA, Abdel-Wahab MM. Protective effect of resveratrol against chronic intermittent hypoxia-induced spatial memory deficits, hippocampal oxidative DNA damage and increased p47Phox NADPH oxidase expression in young rats. Behav Brain Res. 2016;305:65-75.
3. Arslan A, Ozcicek F, Keskin Cimen F, Altuner D, Yarali O, et al. Protective effect of resveratrol against methotrexate-induced oxidative stress in the small intestinal tissues of rats. Int J Clin Exp Med. 2015;8:10491-500.
4. Bedada SK, Yellu NR, Neerati P. Effect of resveratrol treatment on the pharmacokinetics of diclofenac in healthy human volunteers. Phytother Res. 2016;30:397-401.
5. Chang CC, Lin KY, Peng KY, Day YJ, Hung LM. Resveratrol exerts anti-obesity effects in high-fat diet obese mice and displays differential dosage effects on cytotoxicity, differentiation, and lipolysis in 3T3-L1 cells. Endocr J. 2016;63:169-78.
6. Cigremis Y, Akgoz M, Ozen H, Karaman M, Kart A, Gecer M, et al. Resveratrol ameliorates cisplatin-induced oxidative injury in New Zealand rabbits. Can J Physiol Pharmacol. 2015;93:727-35.
7. Das SK, Wang W, Zhabyeyev P, Basu R, McLean B, Fan D, et al. Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy. Sci Rep. 2015;5:18132.
8. Deng N, Chang E, Li M, Ji J, Yao X, Bartish IV, et al. Transcriptome characterization of gnetum parvifolium reveals candidate genes involved in important secondary metabolic pathways of flavonoids and stilbenoids. Front Plant Sci. 2016;7:174.
9. Diaz-Gerevini GT, Repossi G, Dain A, Tarres MC, Das UN, Eynard AR. Beneficial action of resveratrol: How and why? Nutrition. 2016;32:174-8.
10. Dong W, Yang R, Yang J, Yang J, Ding J, Wu H, et al. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway. Int J Clin Exp Pathol. 2015;8:8731-41.
11. Faghihzadeh F, Hekmatdoost A, Adibi P. Resveratrol and liver: A systematic review. J Res Med Sci. 2015;20:797-810.
12. Ge JF, Xu YY, Li N, Zhang Y, Qiu GL, Chu CH, et al. Resveratrol improved the spatial learning and memory in subclinical hypothyroidism rat induced by hemi-thyroid electrocauterization. Endocr J. 2015;62:927-38.
13. Hu P, Zhu W, Zhu C, Jin L, Guan Y, Guan X. Resveratrol fails to affect cocaine conditioned place preference behavior, but alleviates anxiety-like behaviors in cocaine withdrawn rats. Psychopharmacology (Berl). 2016;233:1279-87.
14. Hyatt JP, Nguyen L, Hall AE, Huber AM, Kocan JC, Mattison JA, et al. Muscle-specific myosin heavy chain shifts in response to a long-term high fat/high sugar diet and resveratrol treatment in nonhuman primates. Front Physiol. 2016;7:77.
15. Ishikawa K, He S, Terasaki H, Nazari H, Zhang H, Spee C, et al. Resveratrol inhibits epithelial-mesenchymal transition of retinal pigment epithelium and development of proliferative vitreoretinopathy. Sci Rep. 2015;5:16386.
16. Jang JY, Min JH, Wang SB, Chae YH, Baek JY, Kim M, et al. Resveratrol inhibits collagen-induced platelet stimulation through suppressing NADPH oxidase and oxidative inactivation of SH2 domain-containing protein tyrosine phosphatase-2. Free Radic Biol Med. 2015;89:842-51.
17. Ji G, Wang Y, Deng Y, Li X, Jiang Z. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy. Lipids Health Dis. 2015;14:134.
18. Jin X, Wang K, Liu H, Hu F, Zhao F, Liu J. Protection of bovine mammary epithelial cells from hydrogen peroxide-induced oxidative cell damage by resveratrol. Oxid Med Cell Longev. 2016;2016:2572175.
19. Khazaei M, Karimi J, Sheikh N, Goodarzi MT, Saidijam M, Khodadadi I, et al. Effects of resveratrol on receptor for advanced glycation end products (rage) expression and oxidative stress in the liver of rats with type 2 diabetes. Phytother Res. 2016;30:66-71.
20. Kim C, Baek SH, Um JY, Shim BS, Ahn KS. Resveratrol attenuates constitutive STAT3 and STAT5 activation through induction of PTPε and SHP-2 tyrosine phosphatases and potentiates sorafenib-induced apoptosis in renal cell carcinoma. BMC Nephrol. 2016;17(1).
21. Kim YB, Thwe AA, Kim Y, Yeo SK, Lee C, Park SU. Characterization of cDNA encoding resveratrol synthase and accumulation of resveratrol in tartary buckwheat. Nat Prod Commun. 2013;8:1571-4.
22. Kumar A, Dhar S, Rimando AM, Lage JM, Lewin JR, Zhang X, et al. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer. Ann N Y Acad Sci. 2015;1348:1-9.
23. Lai X, Pei Q, Song X, Zhou X, Yin Z, Jia R et al. The enhancement of immune function and activation of NF-κB by resveratrol-treatment in immunosuppressive mice. Int Immunopharmacol. 2016;33:42-7.
24. Lee CS, Choi EY, Lee SC, Koh HJ, Lee JH, Chung JH. Resveratrol inhibits hypoxia-induced vascular endothelial growth factor expression and pathological neovascularization. Yonsei Med J. 2015;56:1678-85.
25. Li S, Bouzar C, Cottet-Rousselle C, Zagotta I, Lamarche F, Wabitsch M, et al. Resveratrol inhibits lipogenesis of 3 T3-L1 and SGBS cells by inhibition of insulin signaling and mitochondrial mass increase. Biochim Biophys Acta. 2016;1857:643-52.
26. Li W, Cao L, Chen X, Lei J, Ma Q. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway. Oncol Rep. 2016;35:1718-26.
27. Liu FC, Tsai YF, Tsai HI, Yu HP. Anti-Inflammatory and Organ-Protective Effects of Resveratrol in Trauma-Hemorrhagic Injury. Mediators Inflamm. 2015;2015:643763.
28. Lu S, Wang X. The role and potential mechanism of resveratrol in the prevention and control of epilepsy. Future Med Chem. 2015;7:2005-18.
29. Mastromarino P, Capobianco D, Cannata F, Nardis C, Mattia E, De Leo A, et al. Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia. Antiviral Res. 2015;123:15-21.
30. Meftahi G, Ghotbedin Z, Eslamizade MJ, Hosseinmardi N, Janahmadi M. Suppressive effects of resveratrol treatment on the intrinsic evoked excitability of CA1 pyramidal neurons. Cell J. 2015;17:532-9.
31. Meng Z, Li J, Zhao H, Liu H, Zhang G, Wang L, et al. Resveratrol relieves ischemia-induced oxidative stress in the hippocampus by activating SIRT1. Exp Ther Med. 2015;10:525-30.
32. Monserrat Hernández-Hernández E, Serrano-García C, Antonio Vázquez-Roque R, Díaz A, Monroy E, Rodríguez-Moreno A, et al. Chronic administration of resveratrol prevents morphological changes in prefrontal cortex and hippocampus of aged rats. Synapse. 2016;70:206-17.
33. Natalin HM, Garcia AF, Ramalho LN, Restini CB. Resveratrol improves vasoprotective effects of captopril on aortic remodeling and fibrosis triggered by renovascular hypertension. Cardiovasc Pathol. 2016;25:116-9.
34. Ortega I, Duleba AJ. Ovarian actions of resveratrol. Ann N Y Acad Sci. 2015;1348:86-96.
35. Pektaş MB, Sadi G, Akar F. Long-term dietary fructose causes gender-different metabolic and vascular dysfunction in rats: modulatory effects of resveratrol. Cell Physiol Biochem. 2015;37:1407-20.
36. Pereira S, Park E, Moore J, Faubert B, Breen DM, Oprescu AI, et al. Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo. Appl Physiol Nutr Metab. 2015;40:1129-36.
37. Polley KR, Jenkins N, O'Connor P, McCully K. Influence of exercise training with resveratrol supplementation on skeletal muscle mitochondrial capacity. Appl Physiol Nutr Metab. 2016;41:26-32.
38. Rabassa M, Zamora-Ros R, Urpi-Sarda M, Bandinelli S, Ferrucci L, Andres-Lacueva C, et al. Association of habitual dietary resveratrol exposure with the development of frailty in older age: the Invecchiare in Chianti study. Am J Clin Nutr. 2015;102:1534-42.
39. Rai G, Mishra S, Suman S, Shukla Y. Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight. Phytomedicine. 2016;23:233-42.
40. Raj P, Zieroth S, Netticadan T. An overview of the efficacy of resveratrol in the management of ischemic heart disease. Ann N Y Acad Sci. 2015;1348:55-67.
41. Riccioni G, Gammone MA, Tettamanti G, Bergante S, Pluchinotta FR, D'Orazio N. Resveratrol and anti-atherogenic effects. Int J Food Sci Nutr. 2015;66:603-10.
42. Schroeter A, Groh IA, Del Favero G, Pignitter M, Schueller K, Somoza V, et al. Inhibition of topoisomerase II by phase II metabolites of resveratrol in human colon cancer cells. Mol Nutr Food Res. 2015;59:2448-59.
43. Shah A, Reyes LM, Morton JS, Fung D, Schneider J, Davidge ST. Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high-fat diet. J Physiol. 2016;594:1465-82.
44. Sin TK, Yung BY, Yip SP, Chan LW, Wong CS, Tam EW, et al. SIRT1-dependent myoprotective effects of resveratrol on muscle injury induced by compression. Front Physiol. 2015;6:293.
45. Su Q, Pu H, Hu C. Neuroprotection by combination of resveratrol and enriched environment against ischemic brain injury in rats. Neurol Res. 2016;17:1-9.
46. Szkudelski T, Szkudelska K. Resveratrol and diabetes: from animal to human studies. Biochim Biophys Acta. 2015;1852:1145-54.
47. Tan L, Wang W, He G, Kuick RD, Gossner G, Kueck AS, et al. Resveratrol inhibits ovarian tumor growth in an in vivo mouse model. Cancer. 2016;122:722-9.
48. Trung LQ, Espinoza JL, An DT, Viet NH, Shimoda K, Nakao S. Resveratrol selectively induces apoptosis in malignant cells with the JAK2V617F mutation by inhibiting the JAK2 pathway. Mol Nutr Food Res. 2015;59:2143-54.
49. Tsang SW, Guan YF, Wang J, Bian ZX, Zhang HJ. Inhibition of pancreatic oxidative damage by stilbene derivative dihydro-resveratrol: implication for treatment of acute pancreatitis. Sci Rep. 2016;6:22859.
50. Wang B, Liu J, Gong Z. Resveratrol induces apoptosis in K562 cells via the regulation of mitochondrial signaling pathways. Int J Clin Exp Med. 2015;8:16926-33.
51. Yao Y, Li J, Niu Y, Yu JQ, Yan L, Miao ZH, et al. Resveratrol inhibits oligomeric Aβ-induced microglial activation via NADPH oxidase. Mol Med Rep. 2015;12:6133-9.
52. Yaylali A, Ergin K, Ceçen S. Effect of resveratrol on leptin and sirtuin 2 expression in the kidneys in streptozotocin-induced diabetic rats. Anal Quant Cytopathol Histpathol. 2015;37:243-51.
53. Yun H, Park S, Kim MJ, Yang WK, Im DU, Yang KR, et al. AMP-activated protein kinase mediates the antioxidant effects of resveratrol through regulation of the transcription factor FoxO1. FEBS J. 2014;281:4421-38.
54. Zhai JL, Weng XS, Wu ZH, Guo SG. Effect of Resveratrol on Preventing Steroid-induced Osteonecrosis in a Rabbit Model. Chin Med J (Engl). 2016;129:824-30.
55. Zhang E, Guo X, Meng Z, Wang J, Sun J, Yao X, et al. Construction, expression, and characterization of Arabidopsis thaliana 4CL and Arachis hypogaea RS fusion gene 4CL::RS in Escherichia coli. World J Microbiol Biotechnol. 2015;31:1379-85.
56. Zhao L, Wang Y, Wang Z, Xu Z, Zhang Q, Yin M. Effects of dietary resveratrol on excess-iron-induced bone loss via antioxidative character. J Nutr Biochem. 2015;26:1174-82.
57. Zheng S, Zhao S, Li Z, Wang Q, Yao F, Yang L, et al. Evaluating the effect of expressing a peanut resveratrol synthase gene in rice. PLoS One. 2015;10(8):e0136013.
 
 
 

Table 1: The biological and pharmacological properties of resveratrol reported by recent studies

[*] Corresponding Author:

Dr. Jae Kwang Kim, Department of Crop Science, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon, 34134, Korea; Phone: +82-32-835-8241, eMail: kjkpj@inu.ac.kr